Montpellier-based Quantum Surgical has announced a significant €30M loan from the European Investment Bank (EIB), supported by the InvestEU program.
This marks the second instance of EIB backing for Quantum Surgical, following an initial loan in 2021 aimed at the commercial launch of their innovative medical robot, Epione. This new funding will accelerate the commercialization of Epione, designed for the minimally invasive treatment of abdominal and lung cancer, enhancing patient care and treatment outcomes.
Advertisement
Epione: A Leap in Interventional Oncology
Epione represents a breakthrough in interventional radiology, enabling the safe and effective minimally invasive percutaneous ablation of tumors. By inserting one or more needles through the skin, Epione destroys tumors with precision. The device is CE-marked in Europe for abdomen and lung tumors and has received FDA clearance for abdominal tumors, showcasing its wide applicability and regulatory approval for use in critical cancer treatments.
A Global Impact on Cancer Treatment
With over 4 million new cases of abdominal and lung cancers diagnosed annually worldwide, Quantum Surgical’s platform has already treated several hundred patients across the globe. The company’s mission is to provide innovative and effective treatment options on a global scale, with the support of the EIB reinforcing the potential for worldwide adoption of their technology to revolutionize cancer treatment.
Quantum Surgical’s Robotic and AI Integration
Founded in 2017 by CEO Bertin Nahum, Quantum Surgical combines robotics and artificial intelligence for the curative and early treatment of cancers. The company focuses on easing multiple probe procedures, making the treatment of large tumors more predictable and effective. This approach aims to allow more patients to benefit from innovative, better-targeted, and less invasive treatments.
European Support for Healthcare Innovation
The EIB’s continued partnership with Quantum Surgical underscores Europe’s commitment to supporting innovation and promising technologies in the healthcare sector. Ambroise Fayolle, Vice President of the European Investment Bank, highlighted the importance of this financing in demonstrating Europe’s dedication to improving patient lives and well-being on a larger scale through advanced medical technologies.
With this new funding, Quantum Surgical is poised to further its impact on the medical field, offering cutting-edge solutions for the treatment of cancer and contributing to the advancement of minimally invasive surgical technologies.
